Net margin is the percentage of revenue a company keeps as profit after every expense and tax. It is net income divided by revenue, and the table shows both amounts beside the percentage. A higher net margin means more of each sales dollar reaches the bottom line. One-time gains, write-downs and tax items pass through net income, so a single period's net margin can move for reasons unrelated to the underlying business. Quarterly and annual points each use the amounts filed for that same period, so a single quarter can swing with the seasons.
REGENERON PHARMACEUTICALS, INC. net margin for the quarter ending 2026-06-30 was 30.23%, a 20.17% decline year-over-year.
REGENERON PHARMACEUTICALS, INC. net margin for the quarter ending 2026-03-31 was 20.17%, a 24.46% decline year-over-year.
REGENERON PHARMACEUTICALS, INC. net margin for the quarter ending 2025-12-31 was 21.74%, a 10.22% decline year-over-year.
REGENERON PHARMACEUTICALS, INC. net margin for the quarter ending 2025-09-30 was 38.89%, a 7.93% increase year-over-year.
REGENERON PHARMACEUTICALS, INC. net margin for fiscal 2025 was 31.41%, a 1.09% increase from fiscal 2024.
REGENERON PHARMACEUTICALS, INC. net margin for fiscal 2024 was 31.07%, a 3.08% increase from fiscal 2023.
REGENERON PHARMACEUTICALS, INC. net margin for fiscal 2023 was 30.14%, a 15.43% decline from fiscal 2022.
REGENERON PHARMACEUTICALS, INC. net margin for fiscal 2022 was 35.64%, a 29.07% decline from fiscal 2021.